Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CuraChik: Chloroquine for Chikungunya Disease
NCT00391313Phase 3Terminated
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chikungunya fever (CHIKV) comparing Chloroquine with Placebo (2 arms). Primary endpoints: Fever clearance time and Viremia clearance time. Started May 2006; status: terminated.
02
Drugs
chloroquine
03
Conditions
chikungunya fever (CHIKV)
Beyond the preview
Go deeper on NCT00391313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00391313.